Our 2 week high-throughput recombinant antibody production is a leading gene-to-antibody workflow in the industry.
At Biointron, we offer the flexibility to rapidly express large quantities of antibodies at varying scales using HEK293 or CHO cells, both known for their efficiency in recombinant protein expression. We also integrate our recombinant protein service to enhance antibody expression workflows, ensuring optimized outcomes for a wide range of research and therapeutic applications. This enables us deliver high quality antibodies with low endotoxin levels (<1EU/mg) and high purity (>95% by SDS-PAGE).
Our recombinant antibody production services also include:
